|
|
Serum anti-mumps IgG antibody levels among children aged 0 to 4 years in Haishu District |
LI Baojun1, XU Lihua1, TONG Siwei1, WANG Haibin1, MO Qiong2
|
1. Department of Disease Control and Prevention, Haishu District Center for Disease Control and Prevention, Ningbo, Zhejiang 315000, China; 2. Ningbo Municipal Center for Disease Control and Prevention, Ningbo, Zhejiang 315000, China |
|
|
Abstract Objective To investigate the serum anti-mumps IgG antibody levels among children aged 0 to 4 years in Haishu District, Ningbo City, Zhejiang Province, so as to provide insights into improvements for mumps vaccination program. Methods Children aged 0 to 4 years were sampled from Haishu District using a stratified random sampling method in 2016 (before adjustment of the mumps vaccination program) and 2022 (after adjustment of the mumps vaccination program). Participants' demographics were collected using questionnaires, and the coverage of mumps-containing vaccines was collected from the Ningbo Municipal Immunization Information System. Serum anti-mumps IgG antibody was measured using enzyme-linked immunosorbent assay (ELISA), and the seroprevalence of anti-mumps IgG antibody and geometric mean concentration (GMC) were estimated among children aged 0 to 4 years in 2016 and 2022. Results A total of 464 children were enrolled in 2016, including 250 boys (53.88%) and 214 girls (46.12%), and there were 301 children receiving mumps-containing vaccines (64.87%). The seroprevalence of anti-mumps IgG antibody were 48.08%, 34.44%, 81.11%, 84.44% and 84.44%, and GMC were 233.86, 351.77, 333.66, 362.29 and 410.72 U/mL. A total of 456 children were recruited in 2022, including 236 boys (51.75%) and 220 girls (48.25%), and there were 427 children receiving mumps-containing vaccines (93.64%). The seroprevalence of anti-mumps IgG antibody were 72.73%, 95.00%, 100.00%, 98.68% and 99.04%, and GMC were 524.05, 1 229.69, 1 623.64, 788.01 and 738.41 U/mL. Higher seroprevalence and GMC of anti-mumps IgG antibody was seen in 2022 than in 2016 among children at all age groups (P<0.05). Conclusion Following adjustment for vaccination programs, the seroprevalence and GMC of anti-mumps IgG antibody significantly increased among children at ages of 0 to 4 years in Haishu District.
|
Received: 14 February 2023
Revised: 10 April 2023
Published: 15 May 2023
|
|
|
|
|
[1] 李环,吕华坤,周升,等.2004—2018年浙江省流行性腮腺炎流行特征分析[J].预防医学,2020,32(10):1038-1040. [2] 杨宏,马超,丁亚兴,等.2012—2019年中国不同免疫策略地区流行性腮腺炎发病特征[J].中国疫苗和免疫,2021,27(3):242-245. [3] 姚亚萍,严睿,陶明勇,等.2008—2019年浙江省流行性腮腺炎时空分布特征[J].预防医学,2022,34(1):17-21,26. [4] 刘隽,苏琪茹,马超,等.不同免疫策略下流行性腮腺炎发病特症的初步比较分析[J].中国疫苗和免疫,2014,20(6):519-522. [5] 李保军,陈冰冰,袁月荣,等.海曙区流行性腮腺炎流行病学特征及免疫史调查[J].预防医学,2018,30(7):725-727,731. [6] 刘姝,林希建,刘浩.长沙市健康人群流行性腮腺炎抗体水平分析[J].公共卫生与预防医学,2018,29(4):40~42. [7] 马钰,胡伟军,卢涛,等.陕西省2017年健康人群麻疹,风疹和流行性腮腺炎抗体水平监测[J].中国疫苗和免疫,2019,25(4):405-408. [8] 凡娅. 2018年绵阳市健康人群流行性腮腺炎抗体水平分析[J].实用预防医学,2021,28(1):86-87. [9] 高晓丽,姜立坤,刘木子,等.哈尔滨市1~19岁健康人群流行性腮腺炎抗体水平调查[J].中国疫苗和免疫,2018,24(4):425-428. [10] 吕宛玉,史鲁斌,王燕,等.河南省2016年健康人群麻疹、风疹、流行性腮腺炎抗体水平监测[J].中国疫苗和免疫,2017,23(4):393-396,418. [11] 刘宇,刘丽珺,杨庆,等.2018年四川省流行性腮腺炎流行特征和健康人群抗体水平[J].中国疫苗和免疫,2019,25(5):553-556. |
|
|
|